News & Events - Ionetix
Latest News

News & Events

Ionetix Appoints Paul Surdez as Head of Investor Relations
News

Ionetix Appoints Paul Surdez as Head of Investor Relations

August 17, 2026

News

Ionetix Announces Approval of Abbreviated New Drug Application for Gallium Ga-68 Gozetotide (PSMA-11) May 26, 2026

Ionetix Announces Approval of Abbreviated New Drug Application for Gallium Ga-68 Gozetotide (PSMA-11)

Ionetix Completes $30 million+ Financing in a Go-Public Transaction April 21, 2026

Ionetix Completes $30 million+ Financing in a Go-Public Transaction

IONETIX Corporation and AlfaRim Medical B.V. announce a strategic partnership to fast-track commercial production of Actinium-225 June 20, 2025

IONETIX Corporation and AlfaRim Medical B.V. announce a strategic partnership to fast-track commercial production of Actinium-225

IONETIX Invests $25.75M in Delta Township Facility June 6, 2025

IONETIX Invests $25.75M in Delta Township Facility, Creating 53 High-Tech Jobs and Advancing Lansing’s MedTech Leadership

Gov. Whitmer Announces IONETIX Corporation $25.75M Investment in Greater Lansing June 3, 2025

Gov. Whitmer Announces IONETIX Corporation $25.75M Investment in Greater Lansing, Creating 53 New Jobs

1 2 Next Load More Posts

Upcoming Events

Vienna, Austria
Join IONETIX at

EANM 2026

Meet IONETIX at the EANM 26 Congress:

Date: October 17-21, 2026
Location: Vienna, Austria

Learn more
Past Events Archive

Harness the power to deliver advanced radiopharmaceuticals

The time is now to partner with us to gain access to scarce diagnostics and therapeutic radiopharmaceuticals.

Get started now